| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Schall Thomas J. is a Director at Immuneering Corp. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $388K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | IMRX Immuneering Corp | Director | Buy | 21,645 | $4.67 | $101,041.02 | +40.9% | +19.0% | - | |
| Jun 27, 2025 | IMRX Immuneering Corp | Director | Buy | 9,500 | $3.66 | $34,788.05 | +21.9% | +126.6% | - | |
| Jun 17, 2025 | IMRX Immuneering Corp | Director | Buy | 40,485 | $2.21 | $89,277.52 | +1,396% | +331.9% | - | |
| Mar 22, 2024 | IMRX Immuneering Corp | Director | Buy | 2,900 | $2.55 | $7,384.85 | New | -44.7% | -29.4% |